Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study

Saved in:

Bibliographic Details
Main Authors:	Carlomaurizio Montecucco, Sara Monti, Paolo Delvino, Alessandra Milanesi, Alice Bartoletti
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-06-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/2/e005504.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis
by: Ningjun Shao, et al.
Published: (2025-08-01)

Late-onset neutropenia induced by anti-B cell therapy with rituximab in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2022-06-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Response to Rituximab after Failure of Cyclophosphamide in the Induction Treatment in a Patient with cANCA-associated Vasculitis and Pachymeningitis: a Case Report
by: O. Psenak, et al.
Published: (2021-08-01)

Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort
by: Yasuhiro Katsumata, et al.
Published: (2025-01-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
by: Atulya Aman Khosla, et al.
Published: (2023-01-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01)

THE VALUE OF THE RUSSIAN NATIONAL REGISTRY OF PATIENTS WITH ANCA-ASSOCIATED SYSTEMIC VASCULITIS AS AN INNOVATIVE TOOL OF PERSONALIZED INDUCTION AND MAINTENANCE THERAPY
by: T. V. Beketova
Published: (2016-12-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas
by: Simon Bond, et al.
Published: (2024-07-01)

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
by: Shiko Gen, et al.
Published: (2023-01-01)

Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
by: Hannah L. Stacey, et al.
Published: (2024-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

ANCA Vasculitis and Hemophagocytic Lymphohistiocytosis following a Fecal Microbiota Transplant
by: Adam Amlani, et al.
Published: (2018-01-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis
by: Bernhard Hellmich, et al.
Published: (2024-02-01)

Pre-exposure prophylaxis of COVID-19 with tixagevimab/cilgavimab (Evusheld) in 63 rituximab-treated patients with ANCA-associated systemic vasculitis: two-year follow-up results
by: T. V. Beketova, et al.
Published: (2024-11-01)

A case report of metastatic renal cell carcinoma and ANCA associated vasculitis
by: Maddison Taylor, et al.
Published: (2025-07-01)

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
by: van Leeuwen JR, et al.
Published: (2025-01-01)

Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study
by: Moman Aladdin Mohammad, et al.
Published: (2025-04-01)

Checkpoint inhibitor-related renal vasculitis and use of rituximab
by: Noha Abdel-Wahab, et al.
Published: (2020-10-01)

Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy
by: Kawa Mohemed, et al.
Published: (2025-03-01)

WCN25-156 RITUXIMAB MAINTENANCE THERAPY IS EFFECTIVE IN MAINTAINING REMISSION IN STEROID DEPENDENT AND FREQUENT RELAPSING ADULT NEPHROTIC SYNDROME
by: Omri Feder, et al.
Published: (2025-02-01)

Goodpasture’s Syndrome and p-ANCA Associated Vasculitis in a Patient of Silicosiderosis: An Unusual Association
by: Amanjit Bal, et al.
Published: (2014-01-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

Propylthiouracil-induced ANCA-associated vasculitis complicated by granulocytopenia and hemophagocytosis: a case report
by: Huilin Zhou, et al.
Published: (2025-04-01)

Hydralazine-Induced ANCA Vasculitis Presenting With Pericarditis: A Novel Case and Literature Review
by: Ahmed Sami Hammami, et al.
Published: (2025-01-01)